Page 74 - FoodFocusThailand No.198 September 2022

STRATEGIC R&D

Medical Foods Market: Application & Trend Analysis

8,000.0
Chronic Kidney Disease x โรคเบาหวาน
7,000.0 x
Minimal Hepatic Encephalopathy x
x
Chemotherapy Induced Diarrhea 6,000.0 x
x
x โรคอััลไซเมอัร์
Pathogen Related Infections 5,000.0 x
x
Diabetic Neuropathy 4,000.0 x x โรคซึมเศร้า
Revenue (USDMillion)
ADHD x x โรคสมาธิิสั�น
Depression 3,000.0

Alzheimer’s Disease 2,000.0 อัาการท้้อังร่วงท้่�เกิด
จากเคม่บำาบัด
Nutritional Deficiency
1,000.0 x x x x x x x x
x x x x x โรคไตเร้�อัรัง
Orphan Diseases
0.0
Dysphagia 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Chronic Kidney Disease Minimal Hepatic Encephalopathy
Chemotherapy Induced Diarrhoea x Pathogen Related Infections
Others x Diabetic Neuropathy ADHD
Depression Alzheimer’s Disease
Source: WHO, U.S. CDC, FDA, Investor Presentations, Primary Interviews, Grand View Research

growth for medical food is the diet for diabetes neuropathy, followed
respectively by the medical diet for neurological and brain diseases
such as Alzheimer’s disease, depression, and attention deficit
hyperactivity disorder.
The development trend for medical food products, especially food
for the elderly, should focus on the three largest target groups. The
first and most common group is elderly with neurological problems
such as multiple sclerosis, cerebrovascular disease, and dementia that
affects swallowing. The second group is the elderly who lost muscle.
According to the data, muscle loss in older adults will increase from
11.1% in 2016 to 12.9% in 2045. And the third group is those who are
malnourished. There are 2 billion people worldwide who are
malnourished and lack micronutrient foods such as vitamins and iron.
Besides that, more than 40% of hospital patients suffer from malnutrition.
For Thailand, a strategic approach for the development and growth
of the medical food market needs to be through deliberated cooperation
with relevant agencies, both public and private sectors. Both research
and business and marketing support agencies must join forces together.
The first approach is to find strategic partners. Support potential
entrepreneurs in seeking business partners and attract foreign
companies to invest and support the transfer of knowledge production
technology to upgrade the Thai medical food production industry and
expand to the international market. The second approach is the
continuous promotion of research and development in advanced
medical and scientific fields to foster the science and technology
potential of Thai entrepreneurs and increase opportunities for medical
food product development both for domestic and export markets. And
healthy food in Thailand was about USD 6.5 billion in 2020, and it is the third approach is the importance of quality control in the production
expected to reach USD 9 billion by 2025. For Thailand’s medical food, of products on a regular basis. This is to build a reputation and promote
the market value in 2020 is 2,850 million baht and is expected to have awareness in the export market in the long run.
a 20% annual growth rate.
Interestingly, two-thirds of the consumption method of medical food
is oral, and only one-third is enteral. In addition, more than half of medical
food products are in powder form. It was found that the highest market More Information Service Info C011

74 FOOD FOCUS THAILAND SEP 2022

26/8/2565 BE 09:37
70-74_Strategic R&D_Akeanong.indd 74 26/8/2565 BE 09:37
70-74_Strategic R&D_Akeanong.indd 74